Downregulation of a novel human gene, ROGDI, increases radiosensitivity in cervical cancer cells.

Downregulation of a novel human gene, ROGDI, increases radiosensitivity in cervical cancer cells.

Cancer Biol Ther. 2016 Aug 12;:1-9

Authors: Chen YF, Cho JJ, Huang TH, Tseng CN, Huang EY, Cho CL

Abstract
ROGDI is a protein that contains a leucine zipper domain and may be involved in cell proliferation. In addition, ROGDI is associated with genome stability by regulating the activity of a DNA damage marker, γ-H2AX. The role of ROGDI in tumor radiosensitization has not been investigated. Previous studies have indicated that radiosensitivity is associated with DNA repair and the cell cycle. In general, the G2/M DNA damage checkpoint is more sensitive to radiation, whereas the G1/S phase transition is more resistant to radiation. Inhibition of cyclin-dependent kinases (CDKs) can lead to a halt of cell cycle progression and a stay at different phases or checkpoints. Our data show that the downregulation of ROGDI led to a decreased expression of CDK 1, 2, cyclin A, B and resulted in a G2/M phase transition block. In addition, the downregulation of ROGDI increased cell accumulation at the G2 phase as detected using flow cytometry and decreased cell survival as revealed by clonogenic assay in HeLa and C33A cells following irradiation. These findings suggest that the downregulation of ROGDI can mediate radiosensitivity by blocking cells at G2/M, the most radiosensitive phase of the cell cycle, as well as exerting deleterious effects in the form of DNA damage, as shown by increased γ-H2AX activation.

PMID: 27636029 [PubMed - as supplied by publisher]

from Cancer via ola Kala on Inoreader http://ift.tt/2celi6Z
via IFTTT